PIK3CA RELATED OVERGROWTH SPECTRUM
Clinical trials for PIK3CA RELATED OVERGROWTH SPECTRUM explained in plain language.
Never miss a new study
Get alerted when new PIK3CA RELATED OVERGROWTH SPECTRUM trials appear
Sign up with your email to follow new studies for PIK3CA RELATED OVERGROWTH SPECTRUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis study tests two targeted drugs for people with abnormal blood vessels (vascular malformations). One drug, alpelisib, is for slow-flow types; the other, mirdametinib, is for fast-flow types. About 50 participants aged 2 and older will take the drug for 48 weeks to see if thei…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Scientists seek clues to rare overgrowth disease in new study
Knowledge-focused Recruiting nowThis study aims to learn more about Proteus syndrome, a rare condition that causes abnormal growth of bones, skin, and other tissues. Researchers will examine up to 1,500 participants to understand the genetic causes and how the disease changes over time. The study involves medic…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated May 17, 2026 03:15 UTC